Dr. Aderman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24601 SE Stark St
Troutdale, OR 97060Phone+1 503-344-5102Fax+1 503-344-5110
Summary
- Dr. Christopher Aderman is a seasoned Ophthalmologist based in Portland, OR, with a subspecialty in Retinal Disease. A Harvard Medical School graduate, he completed his ophthalmology residency at the University of California, San Francisco, and fellowship training at Wills Eye Hodpital in Philadelphia. Dr. Aderman is well versed in vitreoretinal disease and retina surgery. He has produced numerous research publications on a variety of topics in his field, contributing significantly to the knowledge base on retina practices and ophthalmology. Dr. Aderman has further conducted clinical trials and is involved in numerous phase 2 and phase 3 clinical trials currently in diabetic retinopathy, age related macular degeneration, and retinal vein occlusion.
Education & Training
- University of California (San Francisco)Residency, Ophthalmology, 2013
- University of California (San Francisco)Residency, Ophthalmology, 2013 - 2016
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2012 - 2013
- Harvard Medical SchoolClass of 2012
Certifications & Licensure
- CA State Medical License 2013 - Present
- OR State Medical License 2018 - 2025
- PA State Medical License 2016 - 2018
- MA State Medical License 2012 - 2013
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Dichoptic Virtual Reality Therapy for Amblyopia in Adults Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 4 citationsIncreases in Medicare Spending and Use after Private Equity Acquisition of Retina Practices.Yashaswini Singh, Christopher M Aderman, Zirui Song, Daniel Polsky, Jane M Zhu
Ophthalmology. 2024-02-01 - 1 citationsPrivate equity in ophthalmology: taking the long view.Jane M Zhu, Christopher M Aderman
Current Opinion in Ophthalmology. 2023-09-01 - 5 citationsREVERSIBLE RETINAL TOXICITY IN A PATIENT TAKING AXITINIB.Thomas L. Jenkins, Christopher M. Aderman, Allen C. Ho
Retinal Cases & Brief Reports. 2021-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: